Search

everythinglearnresearchcommunity

for

Search:↓

Certain immune cells in the skin can stop hair from growing.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Topical treatments helped a child with Down syndrome and severe hair loss regrow most of his hair.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Psoriasis worsens in winter in India due to less sunlight and dry skin, needing personalized treatment.

Dengue virus can infect human hair follicle cells and may cause hair loss.

A young child with complete hair loss improved significantly with a combination of hair growth treatments and laser therapy.

In Denmark from 1995 to 2016, hospital-treated alopecia areata cases increased, mostly affecting women and those over 50.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

RV3466F lotion significantly reduces hair loss and improves acute telogen effluvium.

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Effective treatment significantly improves pododermatitis in dogs, reducing symptoms and extending remission.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

Ruxolitinib can cause a delayed skin reaction on the nose.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Baricitinib is effective for Alopecia Areata but requires careful patient history evaluation.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.